Atlas Trials

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Clinical trial NCT00196586 · COMPLETED

Trial details

NCT number
NCT00196586
Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV InfectionsChronic Hepatitis C
Start date
2003-04-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.